Cited by 46Neuroscience and Neural EngineeringRetinal Development and DisordersRetinal Diseases and Treatments

Six-month safety and efficacy of the intelligent retinal implant system II device in retinitis pigmentosa

Muqit, Mahiul M.K., Velikay-Parel, Michaela, Weber, Michel, Dupeyron, Gerard, Audemard, Didier, Corcostegui, Borja, Sahel, José, Le Mer, Yannick·2019·Ophthalmology

Integrity signals

Registry

Crossref · 10.1016/j.ophtha.2018.11.010

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • So far, retinal prostheses have reached marketing approval, and other devices are in preclinical and clinical testing.

    “So far, retinal prostheses have reached marketing approval [23,53,111], and other devices are in preclinical and clinical testing.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Muqit, M. M. K., Velikay-Parel, M., Weber, M., Dupeyron, G., Audemard, D., Corcostegui, B., Sahel, J., & Le Mer, Y.
Affiliations
  • Moorfields Eye Hospital NHS Foundation Trust (GB)
  • Centre Hospitalier Universitaire de Nantes (FR)
  • Centre Hospitalier Universitaire de Nîmes (FR)
  • Institut de la Vision (FR)
Corresponding author
Muqit, Mahiul M.K.
Venue
Ophthalmology
Publisher
Elsevier BV
Published
2019-04
Volume
126
Issue
4
Pages
637-639
ISSN
0161-6420 (ISSN-L)
OpenAlex
W2906397140
Cited by
46
References
5
Citations by year
2026: 6 · 2025: 4 · 2024: 8 · 2023: 6 · 2022: 8 · 2021: 5 · 2020: 6 · 2019: 3
FWCI
1.60
Type
journal article
Language
en
Open access
closed
Locations
  • Ophthalmology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Pixium Vision
  • Foundation Fighting Blindness
  • LabEx LifeSenses (ANR-10-LABX-65)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neural Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
retinal prosthesis, retinitis pigmentosa, visual evoked potentials, visual perception, visual acuity, photoreceptor degeneration, blind patients, device safety and efficacy, six-month follow-up, peripheral vision, inner retinal neurons, electrically evoked responses
MeSH terms
Electrodes, Implanted, Electric Stimulation Therapy, Humans, Middle Aged, Prospective Studies, Retinitis Pigmentosa, Time Factors, Visual Acuity, Visual Fields, Treatment Outcome, Visual Prosthesis, Visual Field Tests

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review